论文部分内容阅读
临近心肌梗塞(梗塞前综合征)的处理、药物疗效及治疗评价,由于后述二点理由而发生困难。其一,该病的后果较冠心病的其他类型更不肯定,病理生理的机理不一,可从一支血管的新鲜改变,引起进行性狭窄,直至由于儿茶酚胺释放到血流,引起冠状血管收缩而导致血流量的减少。其二,“临近心肌梗塞”这一名词,各家应用不一。在文献上可找到的同
Near myocardial infarction (pre-infarction syndrome) treatment, drug efficacy and treatment evaluation, due to the reasons described below two difficulties. First, the consequences of the disease is more uncertain than the other types of coronary heart disease, the different mechanisms of pathophysiology, can be a fresh change in blood vessels, causing progressive stenosis, until the catecholamine release into the bloodstream, causing coronary vasoconstriction Resulting in a decrease in blood flow. Second, the term “near myocardial infarction”, different applications. The same can be found in the literature